Mode
Text Size
Log in / Sign up
N/A N=27 Single-blind Treatment

Effects of Pediatric Aquatic Therapy in Children With Spastic Cerebral Palsy

Spastic Cerebral Palsy

Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcome: Primary: Unit on Gross Motor Function Measure Scale (GMFM) — 5.12; 2.00 units on a scale — p=0.007

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
aquatic therapy (Procedure)
Age
Pediatric · 4+ yrs
Sex
All
Sponsor
Chang Gung Memorial Hospital
Primary completion
Jul 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Unit on Gross Motor Function Measure Scale (GMFM)
5.12; 2.00 0.007 sig
SECONDARY
Daily Living Subscale of Vineland Adaptive Behavior Scale
81.8; 92.1 0.393
SECONDARY
Subscale on Cerebral Palsy Quality of Life Questionnaire for Children
69.6; 68.5 0.332

Summary

Aquatic intervention had been applied in children with neuromotor impairment for years, yet there has been little progress toward objective identifications of therapy goals, interventions, and outcomes. Thus, we attempt to design aquatic intervention activity for children with cerebral palsy to evaluate the effect of hydrotherapy. Purpose: To evaluate the effects of pediatric aquatic therapy on motor performance, daily activity and social participation in children with spastic cerebral palsy. Method: The study enrolled 27 children with spastic cerebral palsy aged from 4 to 12 years old.These children were dived into two groups: traditional rehabilitation therapy (control group), and hospital based pediatric aquatic therapy program. We evaluate the motor performance, daily activity and social participation before and after the intervention and compared the difference in improvement between groups. The measurements include modified Ashworth score, Gross Motor Function Measure (GMFM -66), Vineland Adaptive Behavior Scale (VABS) , and Cerebral Palsy Quality of Life Questionnaire for Children (CPQOL). Expect effect: We suppose pediatric aquatic therapy in spastic cerebral palsy children could improve motor function and daily activity.Children could improve self-esteem and we hypothesize this could improve social participation.

Eligibility Criteria

Inclusion Criteria

  • Children diagnosed as cerebral palsy, spastic type
  • Gross Motor Functional Classification (GMFCS) level II-IV
  • Age: 4-12 y/o
  • Informed consent by parents
  • Modified Ashworth score 2 or3
  • If participant history of epilepsy , well controlled by medication

Exclusion Criteria

  • History of psychiatric diseases
  • Poor controlled epilepsy
  • Received botox injection or surgery in recent three months
  • Children diagnosed as attention deficit hyperactivity disorder(ADHD) or autism
  • Severe mental retardation
  • Active infection (Body temperature > 100°F)
  • Communication problems
  • Bowel incontinence
  • Bladder incontinence
  • Severe cardiovascular disease
  • Infectious skin conditions and open wound
  • Nasogastric tubes or gastrostomy tubes
  • Colostomy ,urostomy or ileostomy bags
  • Acute orthopedic injury with pain and instability
  • Diabetes
  • Chlorine sensitivity
  • Latex allergies
  • Tracheostomy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01049581). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search